Chemomab Therapeutics (CMMB) Short Interest Ratio & Short Volume $1.58 -0.06 (-3.66%) (As of 02:29 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Chemomab Therapeutics Short Interest DataChemomab Therapeutics (CMMB) has a short interest of 162,900 shares, representing 1.29% of the float (the number of shares available for trading by the public). This marks a 74.04% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 185,819 shares to cover all short positions.Current Short Interest162,900 sharesPrevious Short Interest93,600 sharesChange Vs. Previous Month+74.04%Dollar Volume Sold Short$231,318.00Short Interest Ratio0.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares14,360,000 sharesFloat Size12,620,000 sharesShort Percent of Float1.29%Today's Trading Volume52,098 sharesAverage Trading Volume185,819 sharesToday's Volume Vs. Average28% Short Selling Chemomab Therapeutics? Sign up to receive the latest short interest report for Chemomab Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCMMB Short Interest Over TimeCMMB Days to Cover Over TimeCMMB Percentage of Float Shorted Over Time Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Chemomab Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024162,900 shares $231,318.00 +74.0%1.3%0.7 $1.42 10/15/202493,600 shares $122,616.00 +29.1%0.7%0.3 $1.31 9/30/202472,500 shares $113,825.00 +23.7%0.6%0.3 $1.57 9/15/202458,600 shares $104,601.00 -72.8%0.5%0.2 $1.79 8/31/2024215,200 shares $434,704.00 +1,003.6%1.8%1 $2.02 8/15/202419,500 shares $21,060.00 -75.0%0.2%0.1 $1.08 Get the Latest News and Ratings for CMMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202478,000 shares $91,260.00 -25.7%0.7%0.6 $1.17 7/15/2024105,000 shares $114,450.00 +4.5%0.9%1 $1.09 6/30/2024100,500 shares $91,706.15 +0.8%0.8%1 $0.91 6/15/202499,700 shares $112,661.00 +62.1%0.8%1 $1.13 5/31/202461,500 shares $65,805.00 -41.0%0.5%0.6 $1.07 5/15/2024104,200 shares $90,862.40 -10.7%0.9%1.1 $0.87 4/30/2024116,700 shares $81,690.00 -25.1%1.0%0.5 $0.70 4/15/2024155,800 shares $113,734.00 -29.8%1.3%0.7 $0.73 3/31/2024221,900 shares $172,860.10 +14.3%1.9%1 $0.78 3/15/2024194,200 shares $155,224.06 -20.5%1.8%0.8 $0.80 2/29/2024244,300 shares $167,345.50 +549.7%2.5%0.9 $0.69 2/15/202437,600 shares $22,936.00 +15.7%0.4%0.1 $0.61 1/31/202432,500 shares $18,752.50 +5.5%0.3%0 $0.58 1/15/202430,800 shares $17,217.20 -23.8%0.3%0 $0.56 12/31/202340,400 shares $20,604.00 +125.7%0.3%0 $0.51 12/15/202317,900 shares $9,039.50 -84.8%0.1%0 $0.51 11/30/2023117,900 shares $63,548.10 +287.8%1.2%0.1 $0.54 11/15/202330,400 shares $24,836.80 -5.6%0.3%0 $0.82 10/31/202332,200 shares $23,583.28 -28.1%0.3%1.7 $0.73 10/15/202344,800 shares $39,827.20 -2.6%0.5%2.4 $0.89 9/30/202346,000 shares $41,170.00 +23.0%0.5%2 $0.90 9/15/202337,400 shares $40,766.00 -9.2%0.4%0.7 $1.09 8/31/202341,200 shares $45,732.00 -8.9%0.4%0.2 $1.11 8/15/202345,200 shares $50,624.00 -19.6%0.5%0.3 $1.12 7/31/202356,200 shares $71,936.00 -43.4%0.5%0.3 $1.28 7/15/202399,200 shares $139,872.00 +6.6%0.9%0.6 $1.41 6/30/202393,100 shares $121,961.00 -69.1%1.1%0.5 $1.31 6/15/2023301,700 shares $512,890.00 -7.6%3.4%1.8 $1.70 5/31/2023326,500 shares $512,605.00 -22.8%3.7%11.9 $1.57 5/15/2023422,900 shares $689,327.00 -7.3%4.8%5.7 $1.63 4/30/2023456,300 shares $679,887.00 -11.8%4.9%1 $1.49 4/15/2023517,400 shares $838,188.00 +1.5%5.6%1.1 $1.62 3/31/2023510,000 shares $810,900.00 -15.7%5.5%1.1 $1.59 3/15/2023605,200 shares $913,852.00 -8.2%7.1%0.7 $1.51[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin 2/28/2023658,900 shares $1.02 million +457.9%7.7%0.8 $1.55 2/15/2023118,100 shares $237,381.00 +3.9%1.4%0.1 $2.01 1/31/2023113,700 shares $261,510.00 -24.8%1.4%0.3 $2.30 1/15/2023151,200 shares $341,712.00 +269.7%1.8%0.3 $2.26 12/30/202240,900 shares $130,880.00 -19.7%0.5%0.1 $3.20 12/15/202250,900 shares $109,435.00 +155.8%0.6%1 $2.15 11/30/202219,900 shares $41,790.00 -69.9%0.3%0.5 $2.10 11/15/202266,100 shares $134,844.00 +66,000.0%0.8%1.6 $2.04 10/31/2022100 shares $204.00 No ChangeN/A0 $2.04 10/15/2022100 shares $200.00 -93.3%N/A0 $2.00 9/30/20221,500 shares $3,735.00 -83.0%0.0%0 $2.49 9/15/20228,800 shares $28,776.00 -36.7%0.1%0.2 $3.27 8/31/202213,900 shares $45,592.00 -42.3%0.2%0.3 $3.28 8/15/202224,100 shares $94,954.00 +230.1%0.3%0.5 $3.94 7/31/20227,300 shares $22,265.00 +49.0%0.1%0.2 $3.05 7/15/20224,900 shares $15,484.00 -78.0%0.1%0.1 $3.16 6/30/202222,300 shares $82,510.00 +147.8%0.3%0.6 $3.70 6/15/20229,000 shares $31,230.00 -14.3%0.1%0.2 $3.47 5/31/202210,500 shares $32,340.00 +34.6%0.1%0.2 $3.08 5/15/20227,800 shares $21,372.00 -34.5%0.1%0.1 $2.74 4/30/202211,900 shares $37,485.00 +205.1%0.2%0.2 $3.15 4/15/20223,900 shares $14,859.00 -76.8%0.1%0.1 $3.81 3/31/202216,800 shares $80,640.00 -32.5%0.2%0.2 $4.80 3/15/202224,900 shares $98,853.00 -26.1%N/A0.2 $3.97 2/28/202233,700 shares $146,258.00 +6.3%0.4%0.3 $4.34 2/15/202231,700 shares $137,578.00 +40.3%0.4%0.3 $4.34 1/31/202222,600 shares $110,740.00 -31.3%0.3%0.2 $4.90 1/15/202232,900 shares $216,482.00 +22.3%0.4%0.2 $6.58 12/31/202126,900 shares $185,610.00 -12.7%0.3%0.1 $6.90 12/15/202130,800 shares $224,224.00 -1.3%0.4%0.2 $7.28 11/30/202131,200 shares $288,600.00 -37.2%0.4%0.2 $9.25 11/15/202149,700 shares $506,940.00 -21.2%0.6%0.3 $10.20 10/29/202163,100 shares $633,984.63 +444.0%0.7%0.4 $10.05 10/15/202111,600 shares $105,444.00 -42.3%0.1%0.1 $9.09 9/30/202120,100 shares $222,708.00 -52.4%0.2%0.2 $11.08 9/15/202142,200 shares $531,720.00 -48.9%0.5%0.3 $12.60 8/31/202182,600 shares $1.21 million +140.1%1.0%0.3 $14.67 8/13/202134,400 shares $510,496.00 No Change0.4%0.1 $14.84 CMMB Short Interest - Frequently Asked Questions What is Chemomab Therapeutics' current short interest? Short interest is the volume of Chemomab Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 162,900 shares of CMMB short. 1.29% of Chemomab Therapeutics' shares are currently sold short. Learn More on Chemomab Therapeutics' current short interest. What is a good short interest ratio for Chemomab Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CMMB shares currently have a short interest ratio of 1.0. Learn More on Chemomab Therapeutics's short interest ratio. What is a good short interest percentage for Chemomab Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.29% of Chemomab Therapeutics' floating shares are currently sold short. Is Chemomab Therapeutics' short interest increasing or decreasing? Chemomab Therapeutics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 162,900 shares, an increase of 74.0% from the previous total of 93,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Chemomab Therapeutics' float size? Chemomab Therapeutics currently has issued a total of 14,360,000 shares. Some of Chemomab Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Chemomab Therapeutics currently has a public float of 12,620,000 shares. How does Chemomab Therapeutics' short interest compare to its competitors? 1.29% of Chemomab Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Chemomab Therapeutics: Eupraxia Pharmaceuticals Inc. (0.39%), Assertio Holdings, Inc. (6.38%), Quince Therapeutics, Inc. (7.33%), Invivyd, Inc. (11.38%), PowerUp Acquisition Corp. (0.06%), Generation Bio Co. (3.40%), Genenta Science S.p.A. (0.03%), SELLAS Life Sciences Group, Inc. (12.23%), Genelux Co. (5.15%), Relmada Therapeutics, Inc. (3.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Chemomab Therapeutics stock? Short selling CMMB is an investing strategy that aims to generate trading profit from Chemomab Therapeutics as its price is falling. CMMB shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Chemomab Therapeutics? A short squeeze for Chemomab Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CMMB, which in turn drives the price of the stock up even further. How often is Chemomab Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMMB, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Assertio Short Interest Data Invivyd Short Interest Data PowerUp Acquisition Short Interest Data Generation Bio Short Interest Data Genenta Science Short Interest Data SELLAS Life Sciences Group Short Interest Data FibroBiologics Short Interest Data Relmada Therapeutics Short Interest Data Genelux Short Interest Data PMV Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMMB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
